prednisone mibe 100 mg supp.
mibe arzneimittel gmbh - prednisone 0,1 g - suppositoire - 100 mg - prednisone 0.1 g - prednisone
prednisona teva 25 mg comprimidos
teva italia s.r.l. - prednisona - excipientes: lactosa monohidrato,carboximetilalmidon sodico - corticosteroides para uso sistÉmico, monofÁrmacos - glucocorticoides - prednisona
prednisona teva 5 mg comprimidos efg
teva italia s.r.l. - prednisona - excipientes: lactosa monohidrato,carboximetilalmidon sodico - corticosteroides para uso sistÉmico, monofÁrmacos - glucocorticoides - prednisona
prednisona doc generici 25 mg comprimidos
doc generici - prednisona - excipientes: lactosa monohidrato,carboximetilalmidon sodico - corticosteroides para uso sistÉmico, monofÁrmacos - glucocorticoides - prednisona
prednisona doc generici 5 mg comprimidos efg
doc generici - prednisona - excipientes: lactosa monohidrato,carboximetilalmidon sodico - corticosteroides para uso sistÉmico, monofÁrmacos - glucocorticoides - prednisona
prednisona pharmacare 25 mg comprimidos
pharmacare s.r.l. - prednisona - excipientes: lactosa monohidrato,carboximetilalmidon sodico - corticosteroides para uso sistÉmico, monofÁrmacos - glucocorticoides - prednisona
prednisona pharmacare 5 mg comprimidos efg
pharmacare s.r.l. - prednisona - excipientes: lactosa monohidrato,carboximetilalmidon sodico - corticosteroides para uso sistÉmico, monofÁrmacos - glucocorticoides - prednisona
prednisona sejmet 25 mg comprimidos
sejmet pharmaceuticals - prednisona - excipientes: lactosa monohidrato,carboximetilalmidon sodico - corticosteroides para uso sistÉmico, monofÁrmacos - glucocorticoides - prednisona
prednisona sejmet 5 mg comprimidos efg
sejmet pharmaceuticals - prednisona - excipientes: lactosa monohidrato,carboximetilalmidon sodico - corticosteroides para uso sistÉmico, monofÁrmacos - glucocorticoides - prednisona
prednisone- prednisone tablet
hikma pharmaceutical - prednisone (unii: vb0r961hzt) (prednisone - unii:vb0r961hzt) - prednisone 5 mg - prednisone tablets, usp are indicated in the following conditions: - endocrine disorders primary or secondary adrenocortical insufficiency (hydrocortisone or cortisone is the first choice; synthetic analogs may be used in conjunction with mineralocorticoids where applicable; in infancy mineralocorticoid supplementation is of particular importance) congenital adrenal hyperplasia nonsuppurative thyroiditis hypercalcemia associated with cancer - rheumatic disorders as adjunctive therapy for short-term administration (to tide the patient over an acute episode or exacerbation) in: psoriatic arthritis rheumatoid arthritis, including juvenile rheumatoid arthritis (selected cases may require low-dose maintenance therapy) ankylosing spondylitis acute and subacute bursitis acute nonspecific tenosynovitis acute gouty arthritis post-traumatic osteoarthritis synovitis of osteoarthritis epicondylitis - collagen diseases during an exacerbation or as maintenance therapy in selected cases of: systemic